G.ST ANTIVIRALS

gst-antivirals-logo

G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.

#People #Financial #Website #More

G.ST ANTIVIRALS

Social Links:

Industry:
Biotechnology

Founded:
2019-01-01

Address:
Vienna, Wien, Austria

Country:
Austria

Website Url:
http://www.gst-antivirals.com

Total Employee:
1+

Status:
Active

Total Funding:
0

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Amazon Organization Schema Google Apps For Business Google Google Cloud


Current Employees Featured

johannes-stรถckl_image

Johannes Stรถckl
Johannes Stรถckl Co-founder @ G.ST Antivirals
Co-founder

guido-gualdoni_image

Guido Gualdoni
Guido Gualdoni CEO I Co-Founder @ G.ST Antivirals
CEO I Co-Founder
2019-11-01

Founder


guido-gualdoni_image

Guido Gualdoni

johannes-stรถckl_image

Johannes Stรถckl

Investors List

ist-cube_image

IST cube

IST cube investment in Series A - G.ST Antivirals

Official Site Inspections

http://www.gst-antivirals.com

  • Host name: acd89244c803f7181.awsglobalaccelerator.com
  • IP address: 75.2.60.5
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "G.ST Antivirals"

G.ST Antivirals

Apr 9, 2024 G.ST Antivirals is currently working on tackling two indications of high medical โ€ฆSee details»

G.ST Antivirals - Crunchbase Company Profile & Funding

G.ST Antivirals is a clinical-stage biotech company that develops broad-spectrum antivirals against infections of the respiratory tract.See details»

G.ST Antivirals 2025 Company Profile: Valuation, โ€ฆ

May 8, 2020 Information on valuation, funding, cap tables, investors, and executives for G.ST Antivirals. Use the PitchBook Platform to explore the full โ€ฆSee details»

G.ST Antivirals - Vienna BioCenter

G.ST Antivirals is dedicated to the development of therapies against different viruses applying an entirely novel approach of antiviral therapy. The MedUni Vienna spin-off utilizes the viral dependency on the host cell metabolism and โ€ฆSee details»

G.ST Antivirals - LinkedIn

About us G.ST Antivirals applies an innovative host cell-based strategy to develop broad โ€ฆSee details»

G.ST Antivirals - Executive Bio, Top Executies, and Transitions ...

View the organization profile of G.ST Antivirals,Guido Gualdoni holds both an MD and a PhD โ€ฆSee details»

G.ST Antivirals GmbH Company Profile | Wien, Wien, Austria ...

Find company research, competitor information, contact details & financial data for G.ST โ€ฆSee details»

G.ST Antivirals Company Profile - Office Locations, Competitors

G.ST Antivirals has 1 employees across 2 locations. See insights on G.ST Antivirals including โ€ฆSee details»

Life Sciences Directory: G.ST Antivirals GmbH

Organization type RDM biotech/pharma Region Lower Austria Cluster ecoplus Focus human โ€ฆSee details»

xista Ventures: Detail

G.ST Antivirals is a clinical-stage biotech company that develops broad-spectrum antivirals โ€ฆSee details»

Team - G.ST Antivirals

Anna-Dorothea Gorki is an expert in respiratory tract infections trained at the Research Center of Molecular Medicine (CeMM, Austrian Academy of Sciences) and the Medical University of โ€ฆSee details»

G.ST Antivirals - Products, Competitors, Financials, Employees ...

About G.ST Antivirals G.ST Antivirals is a clinical-stage biotech company focused on โ€ฆSee details»

G.ST Antivirals reports start of Phase II trial and announces ...

Vienna, Austria, April 9, 2024 โ€“ G.ST Antivirals, a clinical-stage biotechnology company โ€ฆSee details»

G.ST Antivirals - Profiles & Contacts - Crunchbase

G.ST Antivirals is a clinical-stage biotech company that develops broad-spectrum antivirals โ€ฆSee details»

G.ST Antivirals - EU-Startups

Sep 23, 2021 G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals โ€ฆSee details»

Careers - G.ST Antivirals

G.ST Antivirals is a rapidly growing Start-up at the heart of Viennaโ€™s biotech industry, the โ€ฆSee details»

G.ST Antivirals reports positive Phase I trial results

Jan 25, 2024 G.ST Antivirals reported positive results from Phase I clinical trials on its lead โ€ฆSee details»

News - G.ST Antivirals

May 10, 2022 G.ST Antivirals to expand its innovative host cell-based treatment approach to โ€ฆSee details»

G.ST Antivirals reports positive Phase I trial results for 2-Deoxy-D ...

Vienna, Austria, 25 January 2024 โ€“ G.ST Antivirals, a clinical-stage biotechnology company โ€ฆSee details»

Team - G.ST Antivirals

Guido Gualdoni hat sowohl das Medizinstudium als auch ein PhD-Studium in Immunologie an โ€ฆSee details»

linkstock.net © 2022. All rights reserved